Cargando…
Next generation patient-derived prostate cancer xenograft models
There is a critical need for more effective therapeutic approaches for prostate cancer. Research in this area, however, has been seriously hampered by a lack of clinically relevant, experimental in vivo models of the disease. This review particularly focuses on the development of prostate cancer xen...
Autores principales: | Lin, Dong, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Watahiki, Akira, Dong, Xin, Cheng, Hongwei, Wyatt, Alexander W, Collins, Colin C, Gout, Peter W, Wang, Yuzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023366/ https://www.ncbi.nlm.nih.gov/pubmed/24589467 http://dx.doi.org/10.4103/1008-682X.125394 |
Ejemplares similares
-
Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification
por: Chiang, Yan Ting, et al.
Publicado: (2014) -
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
por: Choi, Stephen Yiu Chuen, et al.
Publicado: (2013) -
What is the next generation therapeutic strategy for castration-resistant prostate cancer
por: Wen, Si-Meng, et al.
Publicado: (2015) -
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model
por: Qu, Sifeng, et al.
Publicado: (2013) -
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
por: Qu, Sifeng, et al.
Publicado: (2018)